Assessing the severity of atopic dermatitis in clinical trials and practice.

[1]  J. Silverberg,et al.  Relationship between EASI and SCORAD severity assessments for atopic dermatitis. , 2017, The Journal of allergy and clinical immunology.

[2]  J. Silverberg,et al.  Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis , 2017, The British journal of dermatology.

[3]  D. Murrell,et al.  A comparison study of clinician‐rated atopic dermatitis outcome measures for intermediate‐ to dark‐skinned patients , 2017, The British journal of dermatology.

[4]  C. Terwee,et al.  Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review , 2017, Allergy.

[5]  A. Armstrong,et al.  Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: A systematic review. , 2016, Journal of the American Academy of Dermatology.

[6]  H. Williams,et al.  Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) , 2016, The British journal of dermatology.

[7]  Å. Svensson,et al.  Usefulness of Rajka & Langeland Eczema Severity Score in Clinical Practice. , 2016, Acta dermato-venereologica.

[8]  J. Schmitt,et al.  Measurement properties of adult quality‐of‐life measurement instruments for eczema: a systematic review , 2016, Allergy.

[9]  H. Williams,et al.  A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standards. , 2016, Journal of the American Academy of Dermatology.

[10]  D. Murrell,et al.  A pilot comparison study of four clinician‐rated atopic dermatitis severity scales , 2015, The British journal of dermatology.

[11]  E. Simpson,et al.  What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study , 2015, The British journal of dermatology.

[12]  J. Schmitt,et al.  Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME) , 2014, The British journal of dermatology.

[13]  Masutaka Furue,et al.  The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. , 2014, The Journal of allergy and clinical immunology.

[14]  Jochen Schmitt,et al.  Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. , 2013, The Journal of allergy and clinical immunology.

[15]  K. H. Kim,et al.  Quality of Life and Disease Severity Are Correlated in Patients with Atopic Dermatitis , 2012, Journal of Korean medical science.

[16]  H. Williams,et al.  Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting , 2012, Allergy.

[17]  M. D. de Bruin‐Weller,et al.  Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  J. Schmitt,et al.  EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference , 2012, Allergy.

[19]  A. Armstrong,et al.  Correction: Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010 , 2011, PLoS ONE.

[20]  H. Williams,et al.  Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. , 2011, The Journal of investigative dermatology.

[21]  H. Williams,et al.  Harmonising Outcome Measures for Eczema (HOME).Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany , 2010, The British journal of dermatology.

[22]  C. Terwee,et al.  The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. , 2010, Journal of clinical epidemiology.

[23]  W. Kirch,et al.  Outpatient care and medical treatment of children and adults with atopic eczema , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[24]  H. Williams,et al.  What are the best outcome measurements for atopic eczema? A systematic review. , 2007, The Journal of allergy and clinical immunology.

[25]  H. Wulf,et al.  Assessment of atopic eczema: clinical scoring and noninvasive measurements , 2007, The British journal of dermatology.

[26]  H. Williams,et al.  Measuring atopic eczema severity visually: which variables are most important to patients? , 2005, Archives of dermatology.

[27]  Rajesh Balkrishnan,et al.  The Burden of Atopic Dermatitis: Impact on the Patient, Family, and Society , 2005, Pediatric dermatology.

[28]  S. Feldman,et al.  Psoriasis assessment tools in clinical trials , 2005, Annals of the rheumatic diseases.

[29]  H. Williams,et al.  The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. , 2004, Archives of dermatology.

[30]  T. Fok,et al.  Validation of a Self‐Administered Questionnaire in Chinese in the Assessment of Eczema Severity , 2003, Pediatric dermatology.

[31]  H. Williams,et al.  Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? , 2003, The Journal of investigative dermatology.

[32]  M. Graeber,et al.  The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis , 2001, Experimental dermatology.

[33]  M. Lahfa,et al.  Safety and Efficacy of 1 Year of Tacrolimus Ointment Monotherapy in Adults With Atopic Dermatitis , 2000 .

[34]  H. Williams,et al.  Outcome measures of disease severity in atopic eczema. , 2000, Archives of dermatology.

[35]  P G Mulder,et al.  Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. , 1999, Acta dermato-venereologica.

[36]  P. Spuls,et al.  Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. , 1998, Archives of dermatology.

[37]  P. Tugwell,et al.  The OMERACT filter for Outcome Measures in Rheumatology. , 1998, The Journal of rheumatology.

[38]  J. English,et al.  Long‐term efficacy and safety of cyclosporin in severe adult atopic dermatitis , 1997, The British journal of dermatology.

[39]  A. Finlay,et al.  Cyclosporine in severe childhood atopic dermatitis: a multicenter study. , 1996, Journal of the American Academy of Dermatology.

[40]  H. Heymans,et al.  Symptomatology and growth in infants with cow's milk protein intolerance using two different whey-protein hydrolysate based formulas in a Primary Health Care setting. , 1995, European journal of clinical nutrition.

[41]  M. Sinisalo,et al.  Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy , 1995, The British journal of dermatology.

[42]  F. Bahmer,et al.  Quantification of the extent and the severity of atopic dermatitis: the ADASI score. , 1991, Archives of dermatology.

[43]  A. Y. Finlay,et al.  Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis , 1991, The Lancet.

[44]  A. Oranje.  Practical issues on interpretation of scoring atopic dermatitis: SCORAD Index, objective SCORAD, patient-oriented SCORAD and Three-Item Severity score. , 2011, Current problems in dermatology.

[45]  R. Cherill,et al.  Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme , 2004, The British journal of dermatology.

[46]  J. Ring,et al.  Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. , 1997, Dermatology.

[47]  Julia Brasch,et al.  Severity Scoring of Atopic Dermatitis: The SCORAD Index , 1993 .

[48]  Abrams Bb.  Atopic dermatitis: elements in clinical study design and analysis. , 1989 .

[49]  G. Rajka,et al.  Grading of the severity of atopic dermatitis. , 1989, Acta dermato-venereologica. Supplementum.

[50]  B. Abrams.  Atopic dermatitis: elements in clinical study design and analysis. , 1989, Acta dermato-venereologica. Supplementum.